Search Within

Joachim Yahalom

  1. "Department of Medicine"
Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (17)
  4. Research Letter (5)
  5. Conference Paper (4)
  6. Review (1)
Groups
  1. Department of Medicine (283)
  2. Radiation Oncology, Department of (283)
  3. Survivorship Research (283)
  4. Hematologic Malignancies, Division of (277)
  5. Center for Hematologic Malignancies (243)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Craig Moskowitz (87)
  3. David Straus (82)
  4. Brandon Imber (73)
  5. Ariela Noy (71)
  6. Steven Horwitz (65)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (33)
  4. 2022 (13)
  5. 2021 (15)
  6. 2020 (13)

More Years

Publications
  1. Blood (81)
  2. International Journal of Radiation Oncology, Biology, Physics (31)
  3. Hematological Oncology (24)
  4. Journal of Clinical Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (19)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (89)
  2. Elsevier Inc. (48)
  3. Wiley Blackwell (27)
  4. American Society of Clinical Oncology (19)
  5. Harborside Press (19)
  6. Nature Publishing Group (13)

More Publishers

Results (283)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Genetic Alterations of CREBBP are associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Lee, J.; Fregonese, B.; Tringale, K. R.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Identifying patterns of failure after initial therapy in primary CNS lymphoma in a large patient cohort
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Vachha, B.; Schaff, L.; Grommes, C.; Imber, B.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save